Dr. Amaria on Genetically Modified TILs in Melanoma
1 Bekeken
• 07/03/23
0
0
insluiten
administrator
abonnees
Rodabe N. Amaria, MD, Department of Melanoma Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, discusses genetically modified tumor infiltrating lymphocytes (TILs) for patients with advanced melanoma.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties